Cancer
Malignant Pancreatic Neoplasm
CI-CAN-00001159Explore in graph →
Top-level903 active trials8 approved drugs63 evidence items
- NCIt
- C9005
- ICD-10
- C25
- DOID
- 1793
- Other
- 1 more code
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00001159Explore in graph →
Clinical trials
3,629 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (516)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00967291 | Mitomycin C and Ifosfamide in Treating Patients With Metastatic Pancreatic Cancer(PACT-11) | terminated | Phase 2 | 21 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00967603 | Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer(PACT-12) | completed | Phase 2 | 56 | IRCCS San RaffaeleOTHER | 1 | Feb 1, 2012 | clinicaltrials |
| NCT00898287 | Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer(SAVIOR) | completed | Phase 1 / Phase 2 | 23 | Piramal Enterprises LimitedINDUSTRY | 1 | Jan 20, 2012 | clinicaltrials |
| NCT00960284 | Gemcitabine or Combination Chemotherapy Followed by Chemoradiation for Stage IB, II, or III Pancreatic Cancer(PACT-7) | completed | Phase 2 / Phase 3 | 102 | IRCCS San RaffaeleOTHER | 1 | Jan 13, 2012 | clinicaltrials |
| NCT00111904 | Paclitaxel in Treating Patients With Unresectable Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 43 | TheradexINDUSTRY | 1 | Dec 14, 2011 | clinicaltrials |
| NCT00786006 | Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer | completed | Phase 2 | 61 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT01268384 | Neoadjuvant FDR GX in Locally Advanced Pancreatic Cancer | completed | Phase 2 | 43 | Asan Medical CenterOTHER | 1 | Dec 6, 2011 | clinicaltrials |
| NCT00593008 | Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer | terminated | Phase 1 | 5 | Massachusetts General HospitalOTHER | 1 | Dec 2, 2011 | clinicaltrials |
| NCT00673504 | First-Line Gemcitabine Chemotherapy With Our Without Sunitinib In Advanced or Metastatic Pancreatic Cancer | completed | Phase 2 | 105 | Central European Society for Anticancer Drug ResearchOTHER | 2 | Dec 1, 2011 | clinicaltrials |
| NCT01016639 | Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer(CORGI) | completed | Phase 1 / Phase 2 | 106 | Lund University HospitalOTHER | 1 | Oct 17, 2011 | clinicaltrials |
| NCT00855985 | Anastomotic Techniques in Pancreaticoduodenectomy(PG/PJ) | unknown | N/A | 312 | Lakeshore HospitalOTHER | 1 | Sep 27, 2011 | clinicaltrials |
| NCT00058149 | Gemcitabine With or Without Oxaliplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer | completed | Phase 3 | — | Eastern Cooperative Oncology GroupNETWORK | 2 | Sep 21, 2011 | clinicaltrials |
| NCT00795977 | Preoperative Intratumor Dendritic Cells Injection Immunotherapy for Patients With Pancreatic Cancer | unknown | Phase 1 / Phase 2 | 20 | Fukushima Medical UniversityOTHER | 1 | Sep 8, 2011 | clinicaltrials |
| NCT00281996 | Imatinib Mesylate and Gemcitabine in Treating Patients With Locally Advanced, Metastatic, or Recurrent Pancreatic Cancer | terminated | Phase 1 | 19 | Northwestern UniversityOTHER | 1 | Aug 26, 2011 | clinicaltrials |
| NCT00280709 | Biliary Metal Stent Study: Metal Stents for Management of Distal Malignant Biliary Obstruction | completed | Phase 4 | 400 | University Hospital, LinkoepingOTHER | 1 | Aug 10, 2011 | clinicaltrials |
| NCT00568646 | Phase 2 Study of Oral MKC-1 in Patients With Unresectable or Metastatic Pancreatic Cancer | completed | Phase 2 | 33 | CASI pharmaceuticals, Inc.INDUSTRY | 1 | Aug 4, 2011 | clinicaltrials |
| NCT00683085 | Human Leukocyte Antigen-A*02:01-restricted Tumor Vessel Specific Peptide Vaccination for Advanced Pancreatic Cancer | terminated | Phase 1 / Phase 2 | 2 | Tokyo UniversityOTHER | 1 | Jul 22, 2011 | clinicaltrials |
| NCT00898781 | Study of Circulating Cancer Cells in Patients With Metastatic Breast, Ovarian, Colon, or Pancreatic Cancer | terminated | — | 80 | Mayo ClinicOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01396668 | Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer | completed | Phase 2 | 35 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT01396681 | Adjuvant Gemcitabine and Cisplatin Followed by Chemoradiation for Resected Pancreatic Cancer | completed | Phase 2 | 70 | Seoul National University HospitalOTHER | 1 | Jul 19, 2011 | clinicaltrials |
| NCT00658801 | Study of Respiratory Gated Proton Beam Radiotherapy for Inoperable Pancreas Carcinoma | terminated | Phase 1 | 4 | National Cancer Center, KoreaOTHER_GOV | 1 | Jul 8, 2011 | clinicaltrials |
| NCT00514163 | GEM vs GEM+TS-1 for Advanced Pancreatic Cancer | completed | Phase 2 | 110 | Japan Clinical Cancer Research OrganizationOTHER | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00810953 | A Safety Study Using Pentamidine in Patients With Pancreatic Cancer Undergoing Standard Therapy | completed | Phase 1 / Phase 2 | 10 | Oncozyme Pharma Inc.INDUSTRY | 1 | Jun 28, 2011 | clinicaltrials |
| NCT00639314 | Trial on the Evaluation of Pylorus-ring in Pancreaticoduodenectomy | completed | N/A | 130 | Wakayama Medical UniversityOTHER | 1 | Jun 27, 2011 | clinicaltrials |
| NCT00415454 | Study Combining Suicide Gene Therapy With Chemoradiotherapy in the Treatment of Non-Metastatic Pancreatic Adenocarcinoma | terminated | Phase 1 | 8 | Henry Ford Health SystemOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT00004087 | Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer | completed | Phase 1 / Phase 2 | 15 | Garden State Cancer Center at the Center for Molecular Medicine and ImmunologyOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT00504998 | Safety/Efficacy Study of Rexin-G to Treat Pancreatic Cancer | completed | Phase 1 / Phase 2 | 20 | Epeius BiotechnologiesINDUSTRY | 1 | Jun 10, 2011 | clinicaltrials |
| NCT00550004 | Phase II Study to Evaluate Efficacy and Safety of RP101 in Combination With Gemcitabine(RP101) | terminated | Phase 2 | 153 | SciClone PharmaceuticalsINDUSTRY | 13 | Jun 8, 2011 | clinicaltrials |
| NCT00326911 | Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer | terminated | Phase 2 | 61 | Eli Lilly and CompanyINDUSTRY | 1 | May 25, 2011 | clinicaltrials |
| NCT00667641 | Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 16 | University of Medicine and Dentistry of New JerseyOTHER | 1 | May 10, 2011 | clinicaltrials |
| NCT01333631 | Valproic Acid With Chemoradiotherapy for Pancreatic Cancer | unknown | Phase 2 | 20 | Soroka University Medical CenterOTHER | 0 | Apr 12, 2011 | clinicaltrials |
| NCT01324856 | Pancreaticogastrostomy Versus Pancreaticojejunostomy in Reconstruction After Cephalic Duodenopancreatectomy(PanAm) | unknown | Phase 1 | 100 | University of BelgradeOTHER | 1 | Apr 11, 2011 | clinicaltrials |
| NCT01333332 | Radiotherapy With Chemotherapy as Neoadjuvant Therapy of Resectable and Borderline Resectable Pancreas Cancer | unknown | Phase 2 | 35 | University of VirginiaOTHER | 1 | Apr 11, 2011 | clinicaltrials |
| NCT00500968 | Study Assessing the Effect of Transpapillary Pancreas Duct Stent in Resection of the Pancreatic Tail | completed | N/A | 50 | Karolinska InstitutetOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT01330823 | L-CARnitine in the Palliative Treatment of Advanced PANcreatic Cancer (CARPAN)(CARPAN) | suspended | Phase 3 | 72 | University Medicine GreifswaldOTHER | 1 | Apr 7, 2011 | clinicaltrials |
| NCT00003332 | Combination Chemotherapy Followed by Chemotherapy and Radiation Therapy and/or Surgery in Treating Patients Who Have Pancreatic Cancer | completed | Phase 1 / Phase 2 | 36 | NYU Langone HealthOTHER | 1 | Mar 28, 2011 | clinicaltrials |
| NCT00003125 | Vaccine Therapy, Interleukin-2, and Sargramostim in Treating Patients With Advanced Tumors | completed | Phase 2 | 24 | Georgetown UniversityOTHER | 1 | Mar 24, 2011 | clinicaltrials |
| NCT00950144 | Studying Pain and Symptom Distress in Patients With Advanced Colon Cancer, Rectal Cancer, Pancreatic Cancer, or Liver Cancer | completed | — | 123 | City of Hope Medical CenterOTHER | 1 | Mar 2, 2011 | clinicaltrials |
| NCT00779688 | A Registry of Patients Undergoing Cellvizio Endomicroscopy and Endoscopic Retrograde Cholangiopancreatography(ERCP) Imaging Procedures for Diagnosing Pancreatic and Bile Duct Cancers | completed | — | 130 | Mauna Kea TechnologiesINDUSTRY | 3 | Feb 10, 2011 | clinicaltrials |
| NCT00005594 | ISIS 2503 in Treating Patients With Advanced Cancer of the Pancreas | completed | Phase 2 | 4 | University of Alabama at BirminghamOTHER | 1 | Jan 4, 2011 | clinicaltrials |
| NCT01266720 | HLA-A*0201 Restricted Peptide Vaccine Therapy With Gemcitabine With Gemcitabine in Patient Pancreatic Cancer (Phase1) | unknown | Phase 1 | 6 | Fukushima Medical UniversityOTHER | 1 | Dec 24, 2010 | clinicaltrials |
| NCT01248663 | Reconstruction Method and Delayed Gastric Emptying After Pancreatic Surgery | completed | N/A | 64 | Medical University of ViennaOTHER | 1 | Nov 25, 2010 | clinicaltrials |
| NCT00192712 | Irinotecan, Gemcitabine and Radiation Therapy for Pancreatic Cancer | completed | Phase 2 / Phase 3 | 20 | Rambam Health Care CampusOTHER | 1 | Nov 10, 2010 | clinicaltrials |
| NCT01219192 | Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure | unknown | Phase 1 | 24 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 28, 2010 | clinicaltrials |
| NCT01218880 | Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer | unknown | Phase 1 | 21 | Beijing Protgen Biotechnology Development Co., Ltd.INDUSTRY | 1 | Oct 19, 2010 | clinicaltrials |
| NCT00428597 | A Study Of Sunitinib Compared To Placebo For Patients With Advanced Pancreatic Islet Cell Tumors | terminated | Phase 3 | 171 | PfizerINDUSTRY | 11 | Oct 11, 2010 | clinicaltrials |
| NCT00902733 | Nurse-Provided Care or Standard Care in Treating Patients With Pancreatic Cancer | completed | N/A | 125 | City of Hope Medical CenterOTHER | 1 | Oct 1, 2010 | clinicaltrials |
| NCT00192842 | Gemcitabine With Curcumin for Pancreatic Cancer | completed | Phase 2 | 17 | Rambam Health Care CampusOTHER | 0 | Sep 22, 2010 | clinicaltrials |
| NCT01182831 | Trial Comparing Two Techniques of Celiac Plexus Neurolysis for Treatment of Pain in Carcinoma Pancreas | unknown | Phase 1 | 100 | Asian Institute of Gastroenterology, IndiaOTHER | 1 | Aug 30, 2010 | clinicaltrials |
| NCT00873353 | Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients(XELTA) | completed | Phase 2 | 32 | Grupo Gallego de Investigaciones OncologicasOTHER | 1 | Aug 18, 2010 | clinicaltrials |
Data updated 22 days agoSource updated Feb 1, 2012source: clinicaltrials